Comparison of Annual and Biannual Mass Antibiotic Administration for Elimination of Infectious Trachoma
Authors:
- Wondu AlemayehuWAWondu Alemayehu
- Takele LakewTLTakele Lakew
- Elizabeth YiEYElizabeth Yi
- Jenafir HouseJHJenafir House
- Jaya D. ChidambaramJCJaya D. Chidambaram
- Zhaoxia ZhouZZZhaoxia Zhou
- Vicky CevallosVCVicky Cevallos
- Kathryn RayKRKathryn Ray
- Kevin Cyrus HongKHKevin Cyrus Hong
- Travis C. PorcoTPTravis C. Porco
- Isabella PhanIPIsabella Phan
- 20 February 2008
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 299 (7) , 778-784
Abstract
Research from JAMA — Comparison of Annual and Biannual Mass Antibiotic Administration for Elimination of Infectious TrachomaKeywords
This publication has 31 references indexed in Scilit:
- Impact of Annual Targeted Treatment on Infectious Trachoma and Susceptibility to ReinfectionJAMA, 2006
- The Unexpected Impact of aChlamydia trachomatisInfection Control Program on Susceptibility to ReinfectionThe Journal of Infectious Diseases, 2005
- Mass antibiotics for trachoma and the Allee effectThe Lancet Infectious Diseases, 2005
- Mass Treatment with Single-Dose Azithromycin for TrachomaNew England Journal of Medicine, 2004
- New Steps toward Eliminating Blinding TrachomaNew England Journal of Medicine, 2004
- Feasibility of Eliminating Ocular Chlamydia trachomatis With Repeat Mass Antibiotic TreatmentsJAMA, 2004
- Eliminating Trachoma in Areas with Limited DiseaseEmerging Infectious Diseases, 2003
- Rationale for Mass Antibiotic Distribution for Trachoma EliminationInternational Ophthalmology Clinics, 2002
- Towards the global elimination of trachomaNature Medicine, 1999
- Global elimination of trachoma: How frequently should we administer mass chemotherapy?Nature Medicine, 1999